AGP Executive Report
Last update: 2 hours agoDrug Safety: The FDA says Major Rugby issued a nationwide recall of certain levothyroxine sodium tablets because they’re “subpotent,” meaning patients may get less medication than intended; consumers are urged to return affected Major and Cardinal brand packages. Gaza Health Crisis: Israeli strikes destroyed or badly damaged medicine warehouses tied to Al-Aqsa Martyrs Hospital in Deir al-Balah, worsening shortages for patients and displaced families. Medicare Costs: CMS will end a temporary Medicare Part D premium subsidy program, raising the prospect of higher monthly drug costs for about 25 million beneficiaries in 2027. Pharma Product Watch: Sun Pharma Distributors ordered a precautionary withdrawal of multiple eye drops, asking partners to stop billing and return stock. Healthcare Systems & Access: Utah begins accepting applications for a new independent medical cannabis pharmacy license in a medically underserved area, aiming to expand legal access. Workforce & Operations: University Hospitals Elyria Medical Center named Sylvia Radziszewski as chief operating officer.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.